Dupilumab for atopic dermatitis in metastatic cancer.

Published in: The Australasian journal of dermatology (2024)

We present a case of a 47-year-old male with severe atopic dermatitis and metastatic renal cell carcinoma managed successfully with dupilumab. This case further supports the safety of dupilumab in patients with active malignancy, an area currently with limited data.

Keyphrases

atopic dermatitis
metastatic renal cell carcinoma
papillary thyroid
squamous cell carcinoma
small cell lung cancer
squamous cell
early onset
big data
machine learning
young adults
drug induced
artificial intelligence